Repeat Dosing of Psilocybin in Migraine Headache

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 10, 2021

Primary Completion Date

November 5, 2023

Study Completion Date

November 5, 2023

Conditions

Migraine Headache

Interventions

DRUG

Psilocybin

10mg Psilocybin

DRUG

Placebo

25mg Diphenhydramine

Trial Locations (1)

VA Connecticut Healthcare System, West Haven

All Listed Sponsors

collaborator

The Wallace Foundation

OTHER

lead

Yale University

OTHER

NCT04218539 - Repeat Dosing of Psilocybin in Migraine Headache | Biotech Hunter | Biotech Hunter